Patents
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
01/2012
01/11/2012CN102309461A Pyridostigmine bromide odor masking dispersible tablets and preparation method thereof
01/11/2012CN102309460A Pyridostigmine bromide odor masking orally disintegrating tablets and preparation method thereof
01/11/2012CN102309438A Midazolam medicament composition as well as preparation method and application thereof
01/11/2012CN101602767B Preparation method of galanthamine
01/10/2012US8093392 Caspase inhibitors and uses thereof
01/10/2012US8093278 Substituted indoles
01/10/2012US8092798 Method of increasing trabecular bone density in a patient in need thereof by an antibody against GDF-8
01/10/2012CA2486183C Protein kinase inhibitors
01/05/2012WO2012002773A2 Phenylcarbamate compound and muscle relaxant containing the same
01/05/2012WO2012001941A1 Prophylactic or ameliorating agent for genetic diseases
01/05/2012WO2012001121A1 Calpain-3 inhibitors for treating muscular dystrophies and cardiomyopathies
01/05/2012US20120004315 Selective Estrogen Receptor Modulator
01/05/2012US20120004311 Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic b-cell lymphoma/leukemia-2 (bcl-2)
01/05/2012US20120004301 Methods for treating restless legs syndrome
01/05/2012US20120004270 Selective Androgen Receptor Modulators
01/05/2012US20120004263 Compounds for the treatment of pathologies associated with aging and degenerative disorders
01/05/2012US20120004217 Therapeutic agents useful for treating pain
01/05/2012US20120004215 N-oxides of diazabicyclononyl pyrimidine derivatives and their medical use
01/05/2012US20120004214 N-oxides of 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives useful as nicotinic acetylcholine receptor ligands
01/05/2012US20120004184 Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2
01/05/2012US20120004178 Biglycan mutants and related therapeutics and methods of use
01/05/2012US20120004174 Gh secretagogues and uses thereof
01/05/2012US20120003212 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8 associated disorders
01/05/2012US20120003200 Biologically active food supplement
01/05/2012US20120003191 Valproic acid, derivatives, analogues, and compositions including same and methods for their therapeutic use
01/05/2012US20120003186 Method for dedifferentiating adipose tissue stromal cells
01/05/2012CA2804344A1 Calpain-3 inhibitors for treating muscular dystrophies and cardiomyopathies
01/05/2012CA2803825A1 Phenylcarbamate compound and muscle relaxant containing the same
01/04/2012EP2402310A1 CCR9 inhibitors and methods of use thereof
01/04/2012EP2402309A1 CCR9 inhibitors and methods of use thereof
01/04/2012CN102307896A Fibronectin type III domain based scaffold compositions, methods and uses
01/04/2012CN102307871A Isoindolinone and related analogs as sirtuin modulators
01/04/2012CN102302565A Stasis eliminating powder for treating soft tissue injury and cervical spondylosis
01/04/2012CN102302492A Methods and compositions for the treatment of neuropathic pain
01/04/2012CN102302461A Dantrolene sodium freeze-dried powder injection for injection and preparation method thereof
01/04/2012CN101716320B Externally applied medical composition for treating orthopedic diseases and preparation method thereof
01/04/2012CN101559198B Medicament for protecting joints and soft tissues
01/03/2012US8088825 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
01/03/2012US8088371 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; coat suture, stent, screw, plate implants with plasma
01/03/2012CA2598786C Composition and method for increasing the anabolic state of muscle cells
01/03/2012CA2445835C 6h-oxazolo[4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
12/2011
12/29/2011WO2011162320A1 Combination of egcg or methylated egcg and a pde inhibitor
12/29/2011WO2011160826A1 Botulinum toxin therapy
12/29/2011WO2011097500A3 The tweak/fn14 system regulates skeletal muscle atrophy and regeneration
12/29/2011US20110319482 Novel treatments
12/29/2011US20110319476 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf
12/29/2011US20110319440 Process for Preparing Spirocyclic Cyclohexane Compounds, Compositions Containing Such Compounds and Method of Using Such Compounds
12/29/2011US20110319413 Piperazine compound capable of inhibiting prostaglandin d synthase
12/29/2011US20110319353 Treatment for spinal muscular atrophy
12/29/2011US20110319330 Methods For Treating Arthritis, Autoimmune Disease, and Ischemia-Reperfusion Injury
12/29/2011US20110319321 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof
12/29/2011US20110319317 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1
12/29/2011US20110319315 Muscle-building agent
12/29/2011US20110318365 Methods for treatment of degenerative disease associated with apoptosis
12/28/2011EP2399910A1 Novel triazine derivative and pharmaceutical composition containing same
12/28/2011EP2399903A1 Ccr9 inhibitors and methods of use thereof
12/28/2011EP2399601A1 Botulinum toxin therapy
12/28/2011EP2399582A1 Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues
12/28/2011EP2398472A2 Methods and preparations for protecting critically ill patients with a polyamine (e.g. spermine, spermidine)
12/28/2011CN102058747B 一种超微粉碎法制备展筋活血散的工艺 Preparation of ultrafine grinding one kind of muscle blood scattered craft exhibition
12/27/2011US8084049 Complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
12/27/2011US8084031 Method for the treatment of inflammatory disorders
12/22/2011WO2011157059A1 Use of isoacteoside or pharmaceutically acceptable saltthereof
12/22/2011US20110313043 Amino Acid Compositions
12/22/2011US20110313042 Amino Acid Compositions
12/22/2011US20110313027 Methods and substances for stimulating muscle regeneration
12/22/2011US20110313000 Ccr9 inhibitors and methods of use thereof
12/22/2011US20110312975 Certain chemical entities, compositions and methods
12/22/2011US20110312971 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/22/2011US20110312960 Pyrazine derivatives and use as pi3k inhibitors
12/22/2011US20110312882 Methods and compositions for increasing the anaerobic working capacity in tissues
12/22/2011US20110311626 Controlled release compositions comprising anti-cholinergic drugs
12/22/2011US20110311531 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/22/2011CA2802441A1 Use of isoacteoside or pharmaceutically acceptable salt thereof
12/21/2011EP2396343A2 Modified virus vectors and methods of making and using the same
12/21/2011EP1937232B1 Nutraceutical composition for the treatment of muscle wasting
12/21/2011EP1534290B1 Novel inhibitors of kinases
12/21/2011CN102288686A 一种中药冻干注射剂中有机溶剂残留的测定方法 Determination of residual organic solvents in a traditional Chinese medicine injections lyophilized
12/21/2011CN102286070A 用于抑制蛋白酶体的化合物 Compounds for inhibiting the proteasome
12/21/2011CN102284016A 内外结合扶正祛邪治疗风湿筋骨病痛症的中药 Inside and rousing treat rheumatic disease pain medicine
12/21/2011CN102283946A 一种治疗四肢抽搐的中药组合物 A therapeutic herbal composition limbs twitch
12/21/2011CN102283921A 一种治疗颈腰椎间盘突出的组方药物 A treatment for cervical and lumbar disc herniation prescription drugs
12/21/2011CN101843593B 一种维库溴铵冻干制剂及其制备方法 One kind of vecuronium lyophilized formulation and preparation method
12/21/2011CN101798306B 钩藤生物碱单体的用途 Uses Uncaria alkaloid monomers
12/21/2011CN101708261B 一种治疗落枕的中药贴剂 A treatment for stiff neck patch medicine
12/21/2011CN101631542B 神经再生剂 Nerve regeneration agent
12/20/2011US8080636 BSL3 antibodies
12/20/2011CA2526211C [1,2,4]triazolo[1,5,a]pyrimidin-2-ylurea derivative and use thereof
12/20/2011CA2492924C Novel piperazinone derivates for the treatment of 5-ht2a receptor-related disorders
12/20/2011CA2477787C Therapeutic methods and uses of sapogenins and their derivatives
12/20/2011CA2326777C Aminocyclohexyl ether compounds and uses thereof
12/15/2011US20110306946 Cell compositions and uses thereof
12/15/2011US20110306630 Pharmaceutical compositions comprising colloidal silicon dioxide
12/15/2011US20110306607 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
12/15/2011US20110305639 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
12/15/2011US20110305636 Compounds, compositions, methods of synthesis, and methods of treatment
12/14/2011EP1513529B1 Triple monoamine reuptake inhibitors for the treatment of chronic pain
12/14/2011CN102274410A 一种泥灸风湿疾病的组合物 The composition of a mud moxibustion rheumatic diseases
12/14/2011CN102274321A 一种治疗伤筋的中药组合物 A therapeutic herbal composition tendon injury
12/14/2011CN102274307A 治疗脑中风引起的偏瘫、肌张力增高、痉挛的中药组合物 Treatment of stroke-induced paralysis, increased muscle tone, spasms of the herbal composition
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 233